Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Consolidated Statements of Operations and Comprehensive Loss

v3.24.1.1.u2
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues    
Total net sales $ 144,050 $ 149,377
Cost of revenues    
Total cost of sales 80,153 83,982
Gross profit 63,897 65,395
Operating expenses    
Research and development, net 23,977 21,475
Selling, general and administrative 64,373 60,717
Total operating expenses 88,350 82,192
Operating loss (24,453) (16,797)
Financial income (expenses), net 1,217 773
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest, Total (23,236) (16,024)
Income tax benefit (expenses) 716 3,775
Share in net profits (losses) of associated companies (2,031) (2,425)
Net loss $ (25,983) $ (22,224)
Earnings Per Share, Basic $ (0.37) $ (0.33)
Weighted average shares outstanding - diluted 69,993 67,583
Comprehensive Loss    
Net loss attributable to non-controlling interests $ (25,983) $ (22,224)
Other comprehensive income (loss), net of tax:    
Foreign currency translation adjustments (2,186) (2,245)
Unrealized Gain (Loss) on Cash Flow Hedging Instruments 682 1,255
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent (1,504) (990)
Comprehensive loss attributable to Stratasys Ltd. (27,487) (23,214)
Products    
Revenues    
Total net sales 99,196 100,971
Cost of revenues    
Total cost of sales 49,757 51,113
Service [Member]    
Revenues    
Total net sales 44,854 48,406
Cost of revenues    
Total cost of sales $ 30,396 $ 32,869